Fig. 7From: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancerCell type annotation and function enrichment analysis by scRNA sequencing of tumor tissues. A Cell Clusters Visualization by UMAP dimension reduction analysis. B Specific markers for cell annotation. C Heatmap of Top5 differential genes between cell types. D Function enrichment analyses on DEGsBack to article page